Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 8961 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Ultragenyx Pharmaceutical Inc.

Celularity Announces 1-for-10 Reverse Stock Split

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Celularity Inc.

Coherus BioSciences Announces New Employment Inducement Grants

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Coherus BioSciences, Inc.

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Genmab A/S

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024
Related companies:  China Pharma Holdings, Inc.

Mastering The Meno(Pause) Transition Summit 3.0: A New Dawn in Women's Health

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024

Global Nano Calcium Carbonate Strategic Business Report 2024-2030: Increase in Plastic Production & Consumption Sets the Tone for Nano CaCO3 Consumption

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024

Global Exoskeleton Robots Business Report 2024-2030: As Defense Departments Lean towards Advanced Technologies, Opportunities Galore for Military Exoskeleton Robots

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024

Castellum, Inc. Announces Closing of $4 Million Revolver with Live Oak Bank

Read more ››
By: GlobeNewswire - 23 Feb 2024

BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  BioCryst Pharmaceuticals, Inc.

Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Biogen Inc.

Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Travere Therapeutics, Inc.

Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Clearmind Medicine Inc.

TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  TG Therapeutics, Inc.

Ocuphire Pharma to Present in the BIO CEO & Investor Conference

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Ocuphire Pharma, Inc.

Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Gamida Cell Ltd.

Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Venus Concept Inc.

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Jasper Therapeutics, Inc

Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update

Read more ››
By: GlobeNewswire - 23 Feb 2024
Related companies:  Biodexa Pharmaceuticals PLC
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑